Novo Integrated Sciences, Inc. (NVOS) vs P3 Health Partners Inc. (PIII)
- Novo Integrated Sciences, Inc. NVOS 0.00 NaN
- P3 Health Partners Inc. PIII 4.05 +6.02%
Novo Integrated Sciences, Inc. and P3 Health Partners Inc. are both Medical Care Facilities companies. P3 Health Partners Inc. is the larger, with a market value of $28.1M against $730.0K — 38.5× the size. Novo Integrated Sciences, Inc. grew revenue faster over the last twelve months: 5.75% against 2.81%. P3 Health Partners Inc. has the higher net margin (−7.19% vs −121.6%) and the lower return on invested capital (−54.2% vs −42.4%). Across the 16 metrics below, Novo Integrated Sciences, Inc. leads on 8 and P3 Health Partners Inc. on 8.
Valuation
Profitability
| Metric | NVOS | PIII | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 43.19% | 4.70% | 30.56% |
| Operating margin | (75.79%) | (9.89%) | 6.62% |
| Net margin | (121.61%) | (7.19%) | 3.08% |
| Free cash flow margin | (38.54%) | (8.68%) | 7.22% |
| Return on equity | (82.67%) | 461.69% | 6.41% |
| Return on assets | (47.76%) | (15.59%) | 2.78% |
| Return on invested capital | (42.44%) | (54.24%) | 7.44% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack